Showing results (41-50 of 182) with videos related to
Sort By:
Pageof 19
The Lancet. Neurology|March 17, 2015
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectivesDaniel Ontaneda, Robert J Fox, Jeremy ChatawayDrugs|March 14, 2024
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and TolerabilityAlise K Carlson, Moein Amin, Jeffrey A CohenRheumatic Diseases Clinics of North America|June 18, 2023
Central Nervous System Vasculitis: Primary Angiitis of the Central Nervous System and Central Nervous System Manifestations of Systemic VasculitisMoein Amin, Ken Uchino, Rula A Hajj-AliJournal of Neuroimaging : Official Journal of the American Society of Neuroimaging|February 9, 2025
Subject-Based Transfer Learning in Longitudinal Multiple Sclerosis Lesion SegmentationSibaji Gaj, Bhaskar Thoomukuntla, Daniel Ontaneda, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical outcome measures for progressive MS trialsDaniel Ontaneda, Jeffrey A Cohen, Maria Pia AmatoJournal of Clinical Neuromuscular Disease|February 25, 2012
Metabolic syndrome in small fiber sensory neuropathyLan Zhou, Jianbo Li, Daniel Ontaneda, et al.Continuum (Minneapolis, Minn.)|April 2, 2026
Treatment of Multiple SclerosisEllen M Mowry, Darin T Okuda, Daniel OntanedaMethods in Molecular Biology (Clifton, N.J.)|March 31, 2018
Detection and Quantification of MicroRNAs in Esophageal AdenocarcinomaMoein Amin, Farhadul Islam, Vinod Gopalan, et al.Current Opinion in Neurology|March 12, 2021
Predicting disability worsening in relapsing and progressive multiple sclerosisSarah B Simmons, Sven Schippling, Gavin Giovannoni, et al.Journal of Neurology|October 21, 2023
Identification and management of subclinical disease activity in early multiple sclerosis: a reviewDaniel Ontaneda, Tanuja Chitnis, Kottil Rammohan, et al.Pageof 19